92% Ninety-two percent of people who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss were no longer taking the drug after three years
Weeks 14: Improved sleep quality (often the first and most consistent effect) Enhanced recovery between training sessions Some users report mild water retention initially Weeks 48: Noticeable changes in body composition lean mass up, fat down (most pronounced in visceral and subcutaneous fat) Skin quality improvements (GH and IGF-1 drive collagen synthesis) Faster soft tissue recovery from training or injury Weeks 816: Sustained lean mass gains Fat loss continues, particularly around the abdomen Anti-aging markers: joint comfort, skin elasticity, energy levels Important calibration: GH peptides won't produce results like supraphysiological anabolic compounds
In the following section, we will explain how the gut microbiota induces neuroinflammation through these pathways based on current research ( Figure 2 )
Our results showed that the serum GLP-1 levels were significantly elevated after NaB treatment, and these findings were supported by previous studies showing that NaB has the ability to promote GLP-1 secretion from enteroendocrine L cells 8,12,37
Practical Details Typical dosing ranges from 200-500mg IM